| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |